Simblion GmbH acquired unknown stake in TELES Aktiengesellschaft Informationstechnologien.

Teles AG is a Germany-based company, formerly known as TELES Informationstechnologien AG. It operates in the pharmaceutical and telecommunications segments. The Company provide services that cover the entire spectrum from analysis of existing infrastructure, requirements and the regulatory framework through investment consulting and development of custom solutions. It helps customers with the configuration, implementation and migration of a new infrastructure solution. The Company's product portfolio comprises Softclients & Mobile Apps that allow users to be reachable via fixed line using computers, tables, mobile phones or office phones. The Company also offers voice application servers and Softswitches for Internet Protocol (IP) networks. In the core business of pharmaceuticals, the focus is on the supply of prescription drugs with a digitized supply chain. Drugs for cancer, autoimmune deficits and combination therapies for personalized medicine are delivered throughout Europe.